Atai Life Sciences N.V. (ATAI)
1.40
0.07 (5.26%)
At close: Jan 15, 2025, 9:32 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -5.57 | -2.93 | -9.24 | -1.11 | -0.57 |
| PS Ratio | 713.23 | 1.78K | 60.17 | n/a | n/a |
| PB Ratio | 0.92 | 1.59 | -3.52 | 1.25 | 0.17 |
| P/FCF Ratio | -2.64 | -3.93 | -19.04 | -5.43 | -1.26 |
| P/OCF Ratio | -2.66 | -3.97 | -19.38 | -5.45 | -1.26 |
| OCF/S Ratio | -267.89 | -448.36 | -3.1 | n/a | n/a |
| Debt / Equity Ratio | 0.08 | 0.06 | -0.00 | 0.02 | 0.00 |
| Quick Ratio | 9.22 | 14.71 | 17.92 | 8.06 | 24.25 |
| Current Ratio | 9.22 | 14.43 | 17.92 | 8.09 | 24.36 |
| Asset Turnover | 0.00 | 0.00 | 0.05 | n/a | n/a |
| Interest Coverage | -47.24 | -75.61 | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.17 | -0.54 | 0.38 | -1.12 | -0.3 |
| Return on Assets (ROA) | -0.14 | -0.46 | -0.32 | -0.92 | -0.28 |
| Return on Capital (ROIC) | -0.46 | -0.51 | -0.35 | -1.05 | 0.03 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 27.90% | 99.77% | n/a | n/a |
| Net Profit Margin | -12.81K% | -60.69K% | -650.82% | n/a | n/a |
| Pretax Profit Margin | -12.51K% | -58.02K% | -670.4% | n/a | n/a |
| Operating Profit Margin | -39.96K% | -62.14K% | -666.49% | n/a | n/a |
| FCF Margin | -26.98K% | -45.28K% | -315.93% | n/a | n/a |
| EBITDA Margin | -11.56K% | -57.95K% | -590.29% | n/a | n/a |